Athira Pharma CEO Mark Litton's 2022 pay jumps 28% to $3.8M
Athira Pharma reports 2022 executive compensation
By ExecPay News
Published: April 5, 2023
Athira Pharma reported fiscal year 2022 executive compensation information on April 5, 2023.
In 2022, three executives at Athira Pharma received on average a compensation package of $2.6M, a 2% increase compared to previous year.
Average pay of disclosed executives at Athira Pharma
Mark Litton, Chief Executive Officer, received $3.8M in total, which increased by 28% compared to 2021. 79% of Litton's compensation, or $3M, was in option awards. Litton also received $234K in non-equity incentive plan, $543K in salary, as well as $85 in other compensation.
Hans Moebius, Chief Medical Officer, received a compensation package of $2.1M, which decreased by 6% compared to previous year. 69% of the compensation package, or $1.5M, was in option awards.
Rachel Lenington, Chief Operating Officer, earned $2M in 2022, a 21% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 5, 2023.